Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06304805
Status:
COMPLETED
Last Update Posted:
2024-04-10
First Post:
2024-03-05
Brief Title:
TGRX-326 Phase III Pharmacokinetic Study
Sponsor:
Shenzhen TargetRx Inc
Organization:
Shenzhen TargetRx Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-19
Completion Date Type:
ACTUAL
First Submit Date:
2024-03-05
First Submit QC Date:
March 5 2024
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-08
Last Update Post Date:
2024-04-10
Last Update Post Date Type:
ACTUAL